Detection of cervical metastases with 11C-tyrosine pet in patients with squamous cell carcinoma of the oral cavity or oropharynx: A comparison with 18F-FDG PET

Head and Neck

Volumn 32, Issue 3, 2010, Pages 368-374

  Krabbe, Christiaan A ^a   Van Der Werff Regelink, Gerreke ^a   Pruim, Jan ^a   Van Der Wal, Jacqueline E ^a   Roodenburg, Jan L N ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

11C tyrosine; 18F FDG; Amino acids; Head and neck squamous cell carcinoma; PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18; TRACER; TYROSINE C 11; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; METASTASIS; MOUTH CARCINOMA; NECK METASTASIS; OROPHARYNX CARCINOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SALIVARY GLAND; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY; SQUAMOUS CELL CARCINOMA OF THE OROPHARYNX; TUMOR LOCALIZATION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARBON RADIOISOTOPES; CARCINOMA, SQUAMOUS CELL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; OROPHARYNGEAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; TYROSINE;

EID: 76249133079     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21192     Document Type: Article

References (38)

1. Close LG, Merkel M, Vuitch MF, Reisch J, Schaefer SD. Computed tomographic evaluation of regional lymph node involvement in cancer of the oral cavity and oropharynx. Head Neck 1989;11:309-317.
2. Freire AR, Lima EN, Almeida OP, Kowalski LP. Computed tomography and lymphoscintigraphy to identify lymph node metastases and lymphatic drainage pathways in oral and oropharyngeal squamous cell carcinomas. Eur Arch Otorhinolaryngol 2003;260:148-152.
3. Stern WB, Silver CE, Zeifer BA, Persky MS, Heller KS. Computed tomography of the clinically negative neck. Head Neck 1990;12:109-113.
4. van den Brekel MW, Castelijns JA, Croll GA, et al. Magnetic resonance imaging vs palpation of cervical lymph node metastasis. Arch Otolaryngol Head Neck Surg 1991;117:663-673.
5. 18F-FDG PET and CT/ MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation. J Nucl Med 2005;46:1136-1143.
6. Curtin HD, Ishwaran H, Mancuso AA, Dalley RW, Caudry DJ, McNeil BJ. Comparison of CT and MR imaging in staging of neck metastases. Radiology 1998;207:123-130.
7. Warburg O. The metabolism of tumors. London: Arnold Constable; 1930; pp 75-327.
8. 18FDG PET. Am J Roentgenol 2005;184:1326-1331.
9. 18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck. J Clin Oncol 2006;24:4371-4376.
10. 18F-FDG PET: a comparison with conventional methods. Eur J Nucl Med 2001; 28:816-821.
11. 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radio-therapy for head and neck carcinoma. J Nucl Med 2003; 44:198-206.
12. 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med 1998;25:1255-1260.
13. 18F- fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis. J Natl Cancer Inst 2008;100:712-720.
14. 18F-FDG PET/ CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI. J Nucl Med 2006;47:755-762.
15. Strauss LG. Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients. Eur J Nucl Med 1996;23:1409-1415.
16. 18F-FDG uptake in reactive neck lymph nodes of oral cancer: relationship to lymphoid follicles. J Nucl Med 2008;49:1053-1059.
17. Jager PL, Vaalburg W, Pruim J, de Vries EG, Langen KJ, Piers DA. Radiolabeled amino acids: basic aspects and clinical applications in oncology. J Nucl Med 2001; 42:432-445.
18. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluoro-deoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992;33:1972-1980.
19. Kubota R, Kubota K, Yamada S, et al. Methionine uptake by tumor tissue: a microautoradiographic comparison with FDG. J Nucl Med 1995;36:484-492.
20. Braams JW, Pruim J, Nikkels PG, Roodenburg JL, Vaalburg W, Vermey A. Nodal spread of squamous cell carcinoma of the oral cavity detected with PET-tyrosine, MRI and CT. J Nucl Med 1996;37:897-901.
21. 11Ctyrosine PET in patients with laryngeal carcinomas: comparison of standardized uptake value and protein synthesis rate. J Nucl Med 2003;44:341-346.
22. 18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleo-philic substitution. J Nucl Med 1986;27:235-238.
23. de Boer JR, van der Laan BF, Pruim J, et al. Carbon-11 tyrosine PET for visualization and protein synthesis rate assessment of laryngeal and hypopharyngeal carcinomas. Eur J Nucl Med Mol Imaging 2002;29:1182-1187.
24. Kole AC, Pruim J, Nieweg OE, et al. PET with L-[1-carbon-11]- tyrosine to visualize tumors and measure protein synthesis rates. J Nucl Med 1997;38:191-195.
25. Pruim J, Willemsen AT, Molenaar WM, et al. Brain tumors: L-[1-C-11]tyrosine PET for visualization and quantification of protein synthesis rate. Radiology 1995; 197:221-226.
26. Kole AC, Plaat BE, Hoekstra HJ, Vaalburg W, Molenaar WM. FDG and L-[1-11C]-tyrosine imaging of soft-tissue tumors before and after therapy. J Nucl Med 1999;40: 381-386.
27. Lindholm P, Leskinen-Kallio S, Minn H, et al. Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine in head and neck cancer. J Nucl Med 1993;34: 1711-1716.
28. Lindholm P, Leskinen S, Lapela M. Carbon-11-methionine uptake in squamous cell head and neck cancer. J Nucl Med 1998;39:1393-1397.
29. 11C]methionine. Int J Radiat Oncol Biol Phys 1994;30:1195-1199.
30. 11C]methionine-positron emission tomography. Radiother Oncol 1999;52:225-232.
31. 18F- fluorodeoxyglucose PET in differentiated thyroid cancer. Nucl Med Commun 2008;29:711-716.
32. 11C-tyrosine PET in patients with laryngeal carcinoma. J Nucl Med 2004;45:2052-2057.
33. 11C-tyrosine PET in patients with laryngeal carcinomas: comparison of standardized uptake value and protein synthesis rate. J Nucl Med 2003;44:341-346.
34. McConathy J, Goodman MM. Non-natural amino acids for tumor imaging using positron emission tomography and single photon emission computed tomography. Cancer Metastasis Rev 2008;27:555-573.
35. Flamen P, Bernheim N, Deron P, et al. Iodine-123 alphamethyl-L- tyrosine single-photon emission tomography for the visualization of head and neck squamous cell carcinomas. Eur J Nucl Med 1998;25:177-181.
36. 18F-FDG PET and CT in patients with head and neck cancer. J Nucl Med 2006;47:256-261.
37. 18F]-fluoro-α-methyltyrosine (FMT) PET: a comparative study with FDG-PET. Ann Nucl Med 2007;21:129-135.
38. 11C]α-methylaminoisobutyric acid in untreated head and neck cancer studied by PET. Eur J Nucl Med 2003;30:72-77.